Revance Therapeutics, Inc. License Agreements
7 Contracts & Agreements
- License and Service Agreement dated February 8, 2007, by and between Revance Therapeutics, Inc. and List Biological Laboratories, Inc (Filed With SEC on May 9, 2023)
- First Addendum to the License and Service Agreement dated April 21, 2009, by and between Revance Therapeutics, Inc. and List Biological Laboratories, Inc (Filed With SEC on May 9, 2023)
- Second Letter Amendment to License Agreement dated (Filed With SEC on May 9, 2023)
- Third Addendum to License and Service Agreement dated December 9, 2021 between Revance Therapeutics, Inc. and List E, LLC (Filed With SEC on May 10, 2022)
- Second Addendum to License and Service Agreement, dated March 2, 2021 between Revance Therapeutics, Inc. and List Biological Laboratories, Inc (Filed With SEC on May 10, 2021)
- Letter Amendment to the License Agreement dated January 8, 2020 by and between Revance Therapeutics, Inc. and Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd (Filed With SEC on February 25, 2021)
- License Agreement, dated December 4, 2018, by and between Revance Therapeutics, Inc. and Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd (Filed With SEC on February 28, 2019)
